Cancer cell fusion: Mechanisms slowly unravel

Felicite K. Noubissi, Brenda M. Ogle

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Although molecular mechanisms and signaling pathways driving invasion and metastasis have been studied for many years, the origin of the population of metastatic cells within the primary tumor is still not well understood. About a century ago, Aichel proposed that cancer cell fusion was a mechanism of cancer metastasis. This hypothesis gained some support over the years, and recently became the focus of many studies that revealed increasing evidence pointing to the possibility that cancer cell fusion probably gives rise to the metastatic phenotype by generating widespread genetic and epigenetic diversity, leading to the emergence of critical populations needed to evolve resistance to the treatment and development of metastasis. In this review, we will discuss the clinical relevance of cancer cell fusion, describe emerging mechanisms of cancer cell fusion, address why inhibiting cancer cell fusion could represent a critical line of attack to limit drug resistance and to prevent metastasis, and suggest one new modality for doing so.

Original languageEnglish (US)
Article number1587
JournalInternational journal of molecular sciences
Volume17
Issue number9
DOIs
StatePublished - Sep 21 2016

Fingerprint

Cell Fusion
Fusion reactions
fusion
cancer
Cells
metastasis
Neoplasms
Neoplasm Metastasis
biological diversity
phenotype
attack
Tumors
emerging
Drug Resistance
Epigenomics
drugs
tumors
Population
Phenotype
cells

Keywords

  • Cell fusion
  • Genetic diversity
  • Genomic instability
  • Metastasis
  • Phosphatidyl serine receptor

Cite this

Cancer cell fusion : Mechanisms slowly unravel. / Noubissi, Felicite K.; Ogle, Brenda M.

In: International journal of molecular sciences, Vol. 17, No. 9, 1587, 21.09.2016.

Research output: Contribution to journalReview article

@article{f1931c16404343dfaf54fd2b49e289f5,
title = "Cancer cell fusion: Mechanisms slowly unravel",
abstract = "Although molecular mechanisms and signaling pathways driving invasion and metastasis have been studied for many years, the origin of the population of metastatic cells within the primary tumor is still not well understood. About a century ago, Aichel proposed that cancer cell fusion was a mechanism of cancer metastasis. This hypothesis gained some support over the years, and recently became the focus of many studies that revealed increasing evidence pointing to the possibility that cancer cell fusion probably gives rise to the metastatic phenotype by generating widespread genetic and epigenetic diversity, leading to the emergence of critical populations needed to evolve resistance to the treatment and development of metastasis. In this review, we will discuss the clinical relevance of cancer cell fusion, describe emerging mechanisms of cancer cell fusion, address why inhibiting cancer cell fusion could represent a critical line of attack to limit drug resistance and to prevent metastasis, and suggest one new modality for doing so.",
keywords = "Cell fusion, Genetic diversity, Genomic instability, Metastasis, Phosphatidyl serine receptor",
author = "Noubissi, {Felicite K.} and Ogle, {Brenda M.}",
year = "2016",
month = "9",
day = "21",
doi = "10.3390/ijms17091587",
language = "English (US)",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "9",

}

TY - JOUR

T1 - Cancer cell fusion

T2 - Mechanisms slowly unravel

AU - Noubissi, Felicite K.

AU - Ogle, Brenda M.

PY - 2016/9/21

Y1 - 2016/9/21

N2 - Although molecular mechanisms and signaling pathways driving invasion and metastasis have been studied for many years, the origin of the population of metastatic cells within the primary tumor is still not well understood. About a century ago, Aichel proposed that cancer cell fusion was a mechanism of cancer metastasis. This hypothesis gained some support over the years, and recently became the focus of many studies that revealed increasing evidence pointing to the possibility that cancer cell fusion probably gives rise to the metastatic phenotype by generating widespread genetic and epigenetic diversity, leading to the emergence of critical populations needed to evolve resistance to the treatment and development of metastasis. In this review, we will discuss the clinical relevance of cancer cell fusion, describe emerging mechanisms of cancer cell fusion, address why inhibiting cancer cell fusion could represent a critical line of attack to limit drug resistance and to prevent metastasis, and suggest one new modality for doing so.

AB - Although molecular mechanisms and signaling pathways driving invasion and metastasis have been studied for many years, the origin of the population of metastatic cells within the primary tumor is still not well understood. About a century ago, Aichel proposed that cancer cell fusion was a mechanism of cancer metastasis. This hypothesis gained some support over the years, and recently became the focus of many studies that revealed increasing evidence pointing to the possibility that cancer cell fusion probably gives rise to the metastatic phenotype by generating widespread genetic and epigenetic diversity, leading to the emergence of critical populations needed to evolve resistance to the treatment and development of metastasis. In this review, we will discuss the clinical relevance of cancer cell fusion, describe emerging mechanisms of cancer cell fusion, address why inhibiting cancer cell fusion could represent a critical line of attack to limit drug resistance and to prevent metastasis, and suggest one new modality for doing so.

KW - Cell fusion

KW - Genetic diversity

KW - Genomic instability

KW - Metastasis

KW - Phosphatidyl serine receptor

UR - http://www.scopus.com/inward/record.url?scp=84988667541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988667541&partnerID=8YFLogxK

U2 - 10.3390/ijms17091587

DO - 10.3390/ijms17091587

M3 - Review article

C2 - 27657058

AN - SCOPUS:84988667541

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 9

M1 - 1587

ER -